PE investment in China biotech has collapsed amid failed IPO processes and disputed valuations. Pockets of activity remain, though questions around commercialisation have yet to be answered
In the second half of 2020, private equity investment in China biotech surged to USD 3.9bn, a threefold increase on the first six months and more than the combined 12-month totals for 2018 and 2019. This...
A Chinese investor group featuring several private equity firms has sold the non-China assets of LifeStyles Healthcare, a global sexual health and wellness platform best known for the Lifestyles condom brand, to US-based Linden Capital Partners.
The Carlyle Group has applied for regulatory approval to acquire a 26% stake in Taiwan-based sushi chain Zhengxian, also known as Sushi Express.
Hong Kong-based insurer FWD Group and Malaysia’s Artem Ventures have set up a MYR 45m (USD 10.2m) VC fund focused on insurance technology and Islamic financial technology in Malaysia.
DeHaat, which claims to be India’s largest full-stack agricultural technology platform, has closed its Series E round on USD 60m. Sofina and Temasek Holdings were the lead investors.